2 months ago
NRIX
AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Analyst Ranking
Top 28%
#1539 out of 5523 analysts
Average Return
+2.42%
Win Rate
52%22 out of 42
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Syndax Pharmaceuticals IncSNDX | +162.00% | $9.21 | $24.13 | 2025-07-15 - 2026-07-14 | Strong Buy |
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-17 - 2021-03-17 | Buy |
Nurix Therapeutics IncNRIX | +94.87% | $12.67 | $24.69 | 2025-07-10 - 2026-07-09 | Strong Buy |
Cullinan Therapeutics IncCGEM | +86.22% | $7.91 | $14.73 | 2025-05-12 - 2026-05-11 | Strong Buy |
Merus NvMRUS | +80.02% | $52.30 | $94.15 | 2024-10-24 - 2025-09-30 | Strong Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
4 months ago
ARM
6 months ago
ASML
8 months ago
ASML
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Syndax Pharmaceuticals IncSNDX | 5 | Strong Buy | $33.00 | +84.77% | Maintains | a month ago |
Iovance Biotherapeutics IncIOVA | 4 | Hold | $7.00 | -36.31% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 3 | Strong Buy | $31.00 | +30.97% | Maintains | 2 months ago |
Asml Holding NvASML | 4 | Buy | $2,623.00 | +48.07% | Maintains | 3 months ago |
Celldex Therapeutics IncCLDX | 1 | Strong Buy | $45.00 | +42.90% | Maintains | 4 months ago |
Nuvalent IncNUVL | 4 | Hold | $124.00 | +0.03% | Downgrades | 4 months ago |
Biontech SeBNTX | 2 | Strong Buy | $135.00 | +36.25% | Upgrades | 4 months ago |
Arm Holdings PLCARM | 1 | Buy | $300.00 | +5.88% | Initiates Coverage On | 4 months ago |
Janux Therapeutics IncJANX | 2 | Hold | $15.00 | -9.53% | Downgrades | 5 months ago |
Jasper Therapeutics IncJSPR | 1 | Hold | $1.50 | +139.62% | Assumes | 6 months ago |
Perspective Therapeutics IncCATX | 3 | Strong Buy | $8.00 | +220.00% | Maintains | 6 months ago |
Sony Group CorpSONY | 2 | Hold | $22.00 | -5.70% | Downgrades | 6 months ago |
Kura Oncology IncKURA | 4 | Strong Buy | $15.00 | +41.38% | Maintains | 7 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $128.00 | +14.29% | Maintains | 7 months ago |
Merus NvMRUS | 2 | Hold | $97.00 | +7.78% | Downgrades | a year ago |
Telix Pharmaceuticals LtdTLX | 1 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | N/A | Maintains | a year ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Jounce Therapeutics IncJNCE | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Adicet Bio IncACET | 1 | Buy | $448.00 | N/A | Initiates Coverage On | 4 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.